Overview

A Trial of TD0019 in Treatment of Cervical Scapulohumeral Syndrome

Status:
Completed
Trial end date:
2018-02-20
Target enrollment:
Participant gender:
Summary
Cervical scapulohumeral syndrome, which is also called scapulohumeral syndrome or cervical radiculopathy is a group of syndromes related to cervical spine disorders with disfunctional nerves and without inflamation. The physical syndromes vary from neck pain, Sensory Processing Disorder/Movenment Disorder of areas dominated by injured nerves. The hard capsule TD0019 is a product based on the traditional prescription named "Độc hoạt tang ký sinh thang" combined with Nattokinase and the extraction of Salix alba Cortex .
Phase:
Phase 2
Details
Lead Sponsor:
Sunstar Joint Stock Company
Collaborator:
Big Leap Clinical Research Joint Stock Company